Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking ...

Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

A similar challenge arises at the microscopic level when lipid nanoparticles (LNPs) - the revolutionary drug delivery vehicles behind the COVID-19 vaccines - attempt to deliver mRNA to cells.

Genetic medicines could treat certain diseases, however, the current delivery systems available—viral vectors and lipid nanoparticles (LNPs)—pose unique challenges for gene therapy applications. For ...

"Everything injected into the bloodstream is eventually ends up in the liver — that's just how our anatomy works," Professor ...

The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.

Vaxxas has announced that the CEPI, has approved the progression of a $7.2 million program to develop heat-stable, ...

A similar challenge arises at the microscopic level when lipid nanoparticles (LNPs) -- the revolutionary drug delivery vehicles behind the COVID-19 vaccines -- attempt to deliver mRNA to cells.